Photrexa cross-linking kit 6ML
Ended Awarded
- Contract number
- SPE2DB25FYQ02
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,183
Award facts
- Contract value 100% obligated
- $11,182.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,182.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-linking Kit in 6ML quantities. This delivery order is issued under the firm fixed-price contract type with an ultimate completion date of September 29, 2025. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis leveraging its woman-owned small business status. Performance will be completed at the awardee's facility in Park Ridge, Illinois.
This delivery order is part of DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at approximately $500 million and extending through November 2026. This master contract enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. Photrexa is a corneal cross-linking solution used in ophthalmic procedures, representing the type of specialized pharmaceutical product within the company's extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables that serve military medical treatment facilities across the nation.
Quick answers
Who was awarded contract SPE2DB25FYQ02?
SPE2DB25FYQ02 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FYQ02 worth?
The government has obligated $11,183 on SPE2DB25FYQ02.
Is contract SPE2DB25FYQ02 an order under another contract?
Yes. SPE2DB25FYQ02 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYQ02 competed?
The extent of competition for SPE2DB25FYQ02 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award